146.00
+2.40
+(1.67%)
At close: 4:38:23 PM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | -0.54 | -0.55 |
| Low Estimate | 0 | 0 | -0.68 | -0.6 |
| High Estimate | 0 | 0 | -0.4 | -0.5 |
| Year Ago EPS | -- | -- | -0.24 | -0.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 11.93M | 13.73M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 30.5M | 28.5M |
| Year Ago Sales | -- | -- | 3.33M | 11.93M |
| Sales Growth (year/est) | -- | -- | 258.36% | 15.08% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.54 | -0.55 |
| 7 Days Ago | 0 | 0 | -0.54 | -0.55 |
| 30 Days Ago | 0 | 0 | -0.54 | -0.55 |
| 60 Days Ago | 0 | 0 | -0.54 | -0.55 |
| 90 Days Ago | 0 | 0 | -0.68 | -0.55 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PRTC.L | -- | -- | -125.21% | -2.13% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Related Tickers
HEMO.L Hemogenyx Pharmaceuticals Plc
357.50
-4.16%
ITH.BE Nektar Therapeutics
0.8120
-2.81%
OBD.L Oxford BioDynamics Plc
0.5000
-16.67%
VAL.L ValiRx plc
0.8000
0.00%
ABVX.PA ABIVAX Société Anonyme
5.94
-1.98%
SCLP.L Scancell Holdings plc
9.75
0.00%
PLRX Pliant Therapeutics, Inc.
10.91
-0.82%
HNSA.ST Hansa Biopharma AB (publ)
32.28
+1.00%
RYTM Rhythm Pharmaceuticals, Inc.
56.81
+0.51%
EWTX Edgewise Therapeutics, Inc.
27.80
-0.18%